ArticleHuman mutation2026
Next-Generation Sequencing to Identify Genetic Causes of Chinese Patients Affected With Non-retinal Developmental Eye Disorders.
Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the genetic causes of non-retinal developmental eye disorders in 14 Chinese different families, we subjected participants to a specific hereditary eye disease enrichment panel (HEDEP) or whole exome sequencing. We further validated disease-causing variants and performed co-segregation analyses on the available family members by Sanger sequencing. We classified sequence changes according to the American College of Medical Genetics and Genomics and the Association for Molecular Pathology variant interpretation guidelines. Fourteen probands with diverse clinical diagnoses were analyzed, including microphthalmia (with or without microcornea and congenital cataract or congenital corneal opacification (CCO), four cases), anterior segment dysgenesis (ASD, six cases)-including Peter's anomaly (PA, one case), PA and microphthalmia (one case), iridocoloboma or aniridia (with microcornea and/or congenital cataract, two cases), and primary congenital glaucoma (PCG, two cases)-congenital cataract (with CCO or microcornea, three cases), and Rubinstein-Taybi syndrome (RSTS, one case). Initial inheritance patterns for 1, 5, and 8 cases were autosomal recessive, autosomal dominant, and sporadic, respectively. We identified 17 (likely) pathogenic variants and one variant of uncertain significance (VUS) in 16 genes, including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.